Code No. | W072-3 | |
Anti-CD358 (DR6) (Human) mAb | ||
Price | ¥52,800 | |
Size | 100 µL (1 mg/mL) | |
Availability (in Japan) | 1-9
(In Japan at 17:00, Jan 14, 2025 in JST) |
|
Clonality | Monoclonal | |
Clone | 3E2E4 | |
Isotype (Immunized Animal) |
Mouse IgG2aκ | |
Applications | FCM 1-10 µg/mL |
|
Immunogen (Antigen) |
Human CD358 (DR6) expressed Ba/F3 transfectants generated from SST-REX (signal sequence trap by retrovirus-mediated expression screening). | |
Reactivity [Gene ID] | Human[27242] |
|
Storage buffer | 1 mg/mL in PBS/50% glycerol, pH 7.2 | |
Storage temp. | -20°C | |
Conjugate | Unlabeled | |
Manufacturer | MBL | |
Alternative names | TNFRSF21, BM-018 | |
Background | Death receptor 6 (DR6), also known as CD358 or TNFRSF21, is a member of the tumor necrosis factor receptor superfamily. DR6 contains a death domain and four TNFR-Cys repeats. It is highly expressed in the heart, brain, placenta, pancreas, lymph nodes, thymus, and prostate. DR6 activates nuclear factor kappa-B and mitogen-activated protein kinase 8 and induces cell apoptosis. Overexpression of DR6 has been observed in several cancers including ovarian cancer and sarcoma. | |
Related products | M076-3 Mouse IgG2a (isotype control) MTG-001 Clear Back (Human Fc receptor blocking reagent) D297-3 Anti-p75NTR (Mouse) mAb M009-3 Anti-Amyloid Precursor Protein mAb W164-3 Anti-RHBDD3 (Human) mAb |
|
Product category | Research area:Cancer Apoptosis Cell surface antigens Tools:Flow cytometry reagents |
|
Data | ||
References |
|